Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)

• Status: Completed
• Trial end date: 2002-09-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare two standard treatment strategies for atrial fibrillation: ventricular rate control and anticoagulation vs. rhythm control and anticoagulation.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Adrenergic Agents; Adrenergic beta-Antagonists; Amiodarone; Digoxin; Diltiazem; Disopyramide; Flecainide; Moricizine; Procainamide; Propafenone; Quinidine; Sotalol; Verapamil

Criteria

Elderly men and women with atrial fibrillation and other risk factors for stroke.